Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03695250
Title BMS-986205 and Nivolumab as First Line Therapy in Treating Patients With Liver Cancer
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Edward Kim
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.